RACHEL STEWART: Open Payments
NPI 1184081218 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 36 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $204 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 12 | $196 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $114 |
| Organon LLC | 5 | $80 |
| MILLICENT US INC | 3 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Exeltis, USA Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $25 |
| Cumberland Pharmaceuticals, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| CONMED Corporation | 1 | $20 |
Products named: ZURZUVAE, NEXPLANON, INTRAROSA, MYFEMBREE, SLYND, Veozah, CALDOLOR, Qelbree.
Industry payments across PA — which companies pay providers there.
